Braidwell’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
Braidwell's NVCT Position: Q3 2026 in Review
Braidwell opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 1,573,823 shares worth $33.2M. The stake represents 1.38% of the portfolio and ranks #26 among its holdings.
94 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- Braidwell held 1,573,823 shares of Nuvectis Pharma worth $33.2M as of Q3 2026.
- Nuvectis Pharma was a new Braidwell position in Q3 2026.
- Nuvectis Pharma made up 1.38% of Braidwell's portfolio in Q3 2026, its #26 holding.
- 94 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on Braidwell's 13F filing for Q3 2026, filed 16 Nov 2026.